New: NCI-funded clinical trial search
Mednet Logo
CommunityRheumatology

How do you explain the concept of CAR-T therapy and why it may work to patients with autoimmune disease who are interested in pursuing a clinical trial?

This question is part of our collaboration with ACR Convergence 2026 to preview a session from this year's meeting. This question is inspired by the session series: "Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · Cleveland Clinic
Answered on

In full transparency, I have not personally obtained informed consent from a patient immediately before CAR-T or a related cellular therapy. My center has a highly active immune therapeutics program, however, and I have spoken and written extensively about this area. I also serve on our health syste...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · University of Michigan
Answered on

When explaining CAR-T therapy, I would first clarify that there are two broad approaches. Autologous CAR-T uses the patient’s own T cells. These cells are collected by leukapheresis, genetically modified to recognize a selected immune-cell target—often CD19 on B cells—expanded, and infused back into...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Rheumatology · University of Cincinnati
Answered on

CAR-T therapy is a treatment designed to give part of your immune system a fresh start.

In lupus, B cells contribute to the immune system mistakenly attacking your own tissues. CAR-T therapy tries to remove these B cells very deeply so that the immune system can rebuild in a healthier way.

We collec...

Join for free or sign in to see the full answer